The question about whether calcium channel blockers are safe is flaring up again

The question about whether calcium channel blockers are safe is flaring up again.

The FDA just held a meeting. They're planning a new warning about using short-acting nifedipine for hypertension or unstable angina...because it seems to increase the risk of heart attacks.

But this warning only applies to short-acting nifedipine...NOT the long-acting versions (Adalat PA, Adalat XL)...or to any of the other calcium blockers. This will be in the press...and patients will be asking you about it. You can continue handing them the letter that we prepared on this subject. It is our PHARM-FaxBACK document # 111011.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote